Literature DB >> 9060570

Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer.

J A Hayman1, D L Fairclough, J R Harris, J C Weeks.   

Abstract

PURPOSE: To assess patients' preferences regarding the trade-off between risks and benefits of radiation therapy after conservative surgery for early-stage breast cancer. PATIENTS AND METHODS: Utilities (measures of preference) of 97 early-stage breast cancer patients treated with conservative surgery and radiation therapy and 20 medical oncology nurses were assessed for five health states using standard gambles.
RESULTS: Patients had the highest mean utility for treatment with conservative surgery and radiation therapy without a local recurrence (0.92), intermediate utilities for treatment with conservative surgery alone followed either by no local recurrence or by a local recurrence salvaged by conservative surgery and radiation therapy (0.88 and 0.87, respectively), and the lowest utilities for treatment with or without radiation therapy followed by a local recurrence salvaged by mastectomy and reconstructive surgery (0.82 and 0.81, respectively). All differences between health states' utilities were significant (P < .0001), except between the two intermediate and two lowest rated health states. None of the clinical or sociodemographic factors examined explained more than 5% of the variability in the patients' utilities or their differences. Nurses' utilities were similar to those of the patients.
CONCLUSIONS: These results strongly suggest that fear of a local recurrence and an actual local recurrence leading to mastectomy have such a negative impact on quality of life that patients are willing to accept the risks and inconvenience of radiation therapy to avoid them. There is also considerable interpatient variability that was not explained by the clinical or sociodemographic factors examined.

Entities:  

Mesh:

Year:  1997        PMID: 9060570     DOI: 10.1200/JCO.1997.15.3.1252

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  18 in total

1.  The effect of individually assessed preference weights on the relationship between holistic utilities and nonpreference-based assessment.

Authors:  S J Jansen; A M Stiggelbout; M A Nooij; J Kievit
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

2.  Chained time trade-off and standard gamble methods. Applications in oesophageal cancer.

Authors:  Paul McNamee; Sharon Glendinning; Jonathan Shenfine; Nick Steen; S Michael Griffin; John Bond
Journal:  Eur J Health Econ       Date:  2004-02

Review 3.  Cost-Effectiveness of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: a Critical Review.

Authors:  Nataniel H Lester-Coll; David J Sher
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

4.  Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing.

Authors:  M Cappelli; L Surh; L Humphreys; S Verma; D Logan; A Hunter; J Allanson
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

5.  Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer.

Authors:  Sounok Sen; Shi-Yi Wang; Pamela R Soulos; Kevin D Frick; Jessica B Long; Kenneth B Roberts; James B Yu; Suzanne B Evans; Anees B Chagpar; Cary P Gross
Journal:  J Natl Cancer Inst       Date:  2014-03-05       Impact factor: 13.506

6.  Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.

Authors:  Jeremy Chancellor; Samuel Aballéa; Alison Lawrence; Rob Sheldon; Sandrine Cure; Juliette Plun-Favreau; Nick Marchant
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.

Authors:  Megan C Roberts; Morris Weinberger; Stacie B Dusetzina; Michaela A Dinan; Katherine E Reeder-Hayes; Lisa A Carey; Melissa A Troester; Stephanie B Wheeler
Journal:  J Clin Oncol       Date:  2015-11-23       Impact factor: 44.544

8.  Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.

Authors:  Megan C Roberts; Morris Weinberger; Stacie B Dusetzina; Michaela A Dinan; Katherine E Reeder-Hayes; Melissa A Troester; Lisa A Carey; Stephanie B Wheeler
Journal:  Breast Cancer Res Treat       Date:  2015-07-28       Impact factor: 4.872

9.  Partial breast irradiation versus whole breast radiotherapy for early-stage breast cancer: a decision analysis.

Authors:  David J Sher; Eve Wittenberg; Alphonse G Taghian; Jennifer R Bellon; Rinaa S Punglia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-29       Impact factor: 7.038

10.  Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.

Authors:  David J Sher; Eve Wittenberg; W Warren Suh; Alphonse G Taghian; Rinaa S Punglia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-27       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.